Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Trial Source

Neither a doctor nor a teaching hospital

Research payments

$2,173,917

284 payments

Through program year 2025, Clinical Trial Source is reported as receiving $2,173,917 in research payments, across 284 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$52,490	24
2024	Research	$79,338	39
2023	Research	$119,295	32
2022	Research	$519,828	13
2021	Research	$76,957	12
2020	Research	$335,668	60
2019	Research	$990,342	104

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $1,045,988 80 payments
Ironwood Pharmaceuticals, Inc $391,078 26 payments
ALK-Abello, Inc $149,158 17 payments
AstraZeneca Pharmaceuticals LP $141,220 14 payments
Genentech, Inc. $117,162 23 payments
Mylan Inc. $86,159 26 payments
Sun Pharmaceutical Industries Inc. $70,719 32 payments
AstraZeneca UK Limited $56,605 3 payments
Regeneron Pharmaceuticals, Inc. $37,722 28 payments
Shire North American Group Inc $35,000 10 payments

Studies the money was for Research payments · program years 2019–2025

A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, DO $511,277 28 payments
C3718-302 $381,903 22 payments
A Phase IV, 12 Week, Randomised, Double Blind Study to Compare Single $302,521 18 payments
Mt-11 $142,611 15 payments
A Randomized, Double-Blind, Parallel Group, Multicenter, Stratified St $92,543 8 payments
Study name not reported $90,666 15 payments
Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $86,159 26 payments
PH Iib of Mstt1041a in Severe Uncontrolled Asthma $85,644 14 payments
Open-label, Uncontrolled, Single dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of AZD7442 in Pediatric Participants Aged ? 29 Weeks Gestational Age to < 18 Years $65,164 2 payments
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata $61,787 29 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.